The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
Jean-Pierre Etchegaray
Advertisement
Jean-Pierre Etchegaray is pharmaceutical development expert at Nestle Skin Health.
Articles by Jean-Pierre Etchegaray
Advertisement
Latest Updated Articles
Determination of Dermal PDE for Pharmaceutical ProductsPublished: January 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Challenges for the Global Manufacturing of Vaccines
5
